Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 1
2013 1
2014 1
2016 1
2017 2
2018 1
2019 2
2020 2
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
[Mood disorders: When should we use repetitive transcranial magnetic stimulation?].
Bulteau S, Guirette C, Brunelin J, Poulet E, Trojak B, Richieri R, Szekely D, Bennabi D, Yrondi A, Rotharmel M, Bougerol T, Dall'Igna G, Attal J, Benadhira R, Bouaziz N, Bubrovszky M, Calvet B, Dollfus S, Foucher J, Galvao F, Gay A, Haesebaert F, Haffen E, Jalenques I, Januel D, Jardri R, Millet B, Nathou C, Nauczyciel C, Plaze M, Rachid F, Vanelle JM, Sauvaget A. Bulteau S, et al. Among authors: attal j. Presse Med. 2019 Jun;48(6):625-646. doi: 10.1016/j.lpm.2019.01.012. Epub 2019 May 31. Presse Med. 2019. PMID: 31155435 Review. French.
Treating patients with schizophrenia deficit with erythropoietin?
Fond G, Macgregor A, Attal J, Larue A, Brittner M, Ducasse D, Capdevielle D. Fond G, et al. Among authors: attal j. Psychiatry Clin Neurosci. 2012 Aug;66(5):375-82. doi: 10.1111/j.1440-1819.2012.02359.x. Epub 2012 Jun 22. Psychiatry Clin Neurosci. 2012. PMID: 22725970 Free article. Review.
The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administration with paliperidone palmitate 3-monthly as maintenance treatment for schizophrenia.
Pungor K, Sanchez P, Pappa S, Attal J, Leopold K, Steegen G, Vita A, Marsella C, Verrijcken C, Lahaye M, Wooller A. Pungor K, et al. Among authors: attal j. BMC Psychiatry. 2021 Jun 9;21(1):300. doi: 10.1186/s12888-021-03305-z. BMC Psychiatry. 2021. PMID: 34107886 Free PMC article.
Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial.
Brunelin J, Mondino M, Haesebaert J, Attal J, Benoit M, Chupin M, Dollfus S, El-Hage W, Galvao F, Jardri R, Llorca PM, Magaud L, Plaze M, Schott-Pethelaz AM, Suaud-Chagny MF, Szekely D, Fakra E, Poulet E. Brunelin J, et al. Among authors: attal j. Trials. 2021 Dec 28;22(1):964. doi: 10.1186/s13063-021-05928-9. Trials. 2021. PMID: 34963486 Free PMC article.
Attitudes towards Vaccines, Intent to Vaccinate and the Relationship with COVID-19 Vaccination Rates in Individuals with Schizophrenia.
Raffard S, Bayard S, Eisenblaetter M, Attal J, Andrieu C, Chereau I, Fond G, Leignier S, Mallet J, Tattard P, Urbach M, Misdrahi D, Laraki Y, Capdevielle D. Raffard S, et al. Among authors: attal j. Vaccines (Basel). 2022 Jul 31;10(8):1228. doi: 10.3390/vaccines10081228. Vaccines (Basel). 2022. PMID: 36016116 Free PMC article.
A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).
Moulier V, Krir MW, Dalmont M; SURECT Group, Guillin O, Rothärmel M. Moulier V, et al. Trials. 2021 Apr 15;22(1):284. doi: 10.1186/s13063-021-05227-3. Trials. 2021. PMID: 33858488 Free PMC article.
20 results